Evicenter
P&T meetings

Anaphylm (dibutepinephrine)

Type I allergic reactions including anaphylaxis

Also known as AQST-109
Regulatory submission
NDA resubmitted September 2026
Launch
Not announced
Last updated
121 sources

Product information and disease descriptionProduct descriptionProduct informationPharmacology

Mechanism of action

11 evidence topics · 10 sources

Ester prodrug lipophilicity: log P of the first-generation epinephrine prodrug dipivefrin